0

HIV Collection
 101-120 of 440 Articles
Brief Communications |  15 October 2002
Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy
Louis Bernard, MD; Albert Vuagnat, MD; Gilles Peytavin, MD; et al.
Ann Intern Med. 2002;137(8):656-659. doi:10.7326/0003-4819-137-8-200210150-00009
Clinical Guidelines |  3 September 2002 FREE
Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*
Prepared by Henry Masur, MD; Jonathan E. Kaplan, MD; King K. Holmes, MD, PhD
Ann Intern Med. 2002;137(5_Part_2):435-478. doi:10.7326/0003-4819-137-5_Part_2-200209031-00002
Clinical Guidelines |  3 September 2002 FREE
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
Mark Dybul, MD; Anthony S. Fauci, MD; John G. Bartlett, MD; et al.
Ann Intern Med. 2002;137(5_Part_2):381-433. doi:10.7326/0003-4819-137-5_Part_2-200209031-00001
Current Clinical Issues |  20 August 2002
Chronic HIV Infection: Can Anyone Afford a Drug Holiday?
Brigid Kane
Ann Intern Med. 2002;137(4):301-304. doi:10.7326/0003-4819-137-4-200208200-00031
Editorials |  20 August 2002
Discontinuing Prophylaxis against Recurrent Opportunistic Infections in HIV-Infected Persons: A Victory in the Era of HAART
Jonathan E. Kaplan, MD; Henry Masur, MD; King K. Holmes, MD, PhD
Ann Intern Med. 2002;137(4):285-287. doi:10.7326/0003-4819-137-4-200208200-00013
Articles |  2 July 2002 FREE
High Prevalence of Osteonecrosis of the Femoral Head in HIV-Infected Adults
Kirk D. Miller, MD; Henry Masur, MD; Elizabeth C. Jones, MD, MPH; et al.
Ann Intern Med. 2002;137(1):17-25. doi:10.7326/0003-4819-137-1-200207020-00008
Resource Corner |  May/Jun 2002
The Desktop Guide to Complementary and Alternative Medicine: An Evidence-based Approach
Kumanan Wilson, MD
Ann Intern Med. 2002;136(3):A14. doi:10.7326/ACPJC-2002-136-3-A14
Medicine and Public Policy |  19 February 2002
Legal, Financial, and Public Health Consequences of HIV Contamination of Blood and Blood Products in the 1980s and 1990s
Peter D. Weinberg, MBA; Jennie Hounshell, BA; Laurence A. Sherman, MD, JD; et al.
Ann Intern Med. 2002;136(4):312-319. doi:10.7326/0003-4819-136-4-200202190-00011
Reviews |  5 February 2002
Evaluation and Management of HIV-Infected Women
Alexandra M. Levine, MD
Ann Intern Med. 2002;136(3):228-242. doi:10.7326/0003-4819-136-3-200202050-00011
Articles |  4 December 2001
Predictors of Virologic and Clinical Outcomes in HIV-1–Infected Patients Receiving Concurrent Treatment with Indinavir, Zidovudine, and Lamivudine: AIDS Clinical Trials Group Protocol 320
Lisa M. Demeter, MD; Michael D. Hughes, PhD; Robert W. Coombs, MD, PhD; et al.
Ann Intern Med. 2001;135(11):954-964. doi:10.7326/0003-4819-135-11-200112040-00007
Current Clinical Issues |  20 November 2001
Reasons for Sex-Specific and Gender-Specific Study of Health Topics
Deborah Gesensway
Ann Intern Med. 2001;135(10):935-938. doi:10.7326/0003-4819-135-10-200111200-00032
Articles |  6 November 2001
Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
John P.A. Ioannidis, MD; Philip S. Rosenberg, PhD; James J. Goedert, MD; et al.
Ann Intern Med. 2001;135(9):782-795. doi:10.7326/0003-4819-135-9-200111060-00008
Editorials |  16 October 2001
Twenty Years into the HIV Epidemic, Do We CARE Enough To Manage It Well?
William C. Holmes, MD, MSCE; Kevin R. Conare, MTS
Ann Intern Med. 2001;135(8_Part_1):610-612. doi:10.7326/0003-4819-135-8_Part_1-200110160-00012
Articles |  16 October 2001
Effect of Case Management on Unmet Needs and Utilization of Medical Care and Medications among HIV-Infected Persons
Mitchell H. Katz, MD; William E. Cunningham, MD, MPH; John A. Fleishman, PhD; et al.
Ann Intern Med. 2001;135(8_Part_1):557-565. doi:10.7326/0003-4819-135-8_Part_1-200110160-00006
Articles |  3 July 2001
Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease
Edward L. Murphy, MD, MPH; Ann C. Collier, MD; Leslie A. Kalish, ScD; et al.
Ann Intern Med. 2001;135(1):17-26. doi:10.7326/0003-4819-135-1-200107030-00005
Current Clinical Issues |  15 May 2001
Should We Treat Acute HIV Infection?
Brigid Kane
Ann Intern Med. 2001;134(10):1011-1013. doi:10.7326/0003-4819-134-10-200105150-00022
Editorials |  15 May 2001
Improving on a Coin Toss To Predict Patient Adherence to Medications
Barbara J. Turner, MD, MSEd; Frederick M. Hecht, MD
Ann Intern Med. 2001;134(10):1004-1006. doi:10.7326/0003-4819-134-10-200105150-00015
Reviews |  15 May 2001
Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics*
Christine M. Hogan, MD; Scott M. Hammer, MD
Ann Intern Med. 2001;134(10):978-996. doi:10.7326/0003-4819-134-10-200105150-00012
Academia and the Profession |  15 May 2001
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
Honghu Liu, PhD; Carol E. Golin, MD; Loren G. Miller, MD, MPH; et al.
Ann Intern Med. 2001;134(10):968-977. doi:10.7326/0003-4819-134-10-200105150-00011
Reviews |  1 May 2001
Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses*
Christine M. Hogan, MD; Scott M. Hammer, MD
Ann Intern Med. 2001;134(9_Part_1):761-776. doi:10.7326/0003-4819-134-9_Part_1-200105010-00013
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)